Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
about
Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseasesAnimal models for influenza virus pathogenesis, transmission, and immunologyInfluenza and Memory T Cells: How to Awake the ForceHigh-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responsesNew aspects of influenza viruses.The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.Adenoviral vectors as novel vaccines for influenza.A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virusGeneration and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccineAntibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaquesIdentification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus.Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.Functional CD32 molecules on human NK cells.Fc functional antibodies in humans with severe H7N9 and seasonal influenzaRelationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in childreDistinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccinesA novel adjuvant for vaccine development in the agedInfluence of maternal antibodies on neonatal immunization against respiratory viruses.Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils.The functional impairment of natural killer cells during influenza virus infection.Role for macrophage inflammatory protein 2 (MIP-2), MIP-1alpha, and interleukin-1alpha in the delayed-type hypersensitivity response to viral antigen.Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodiesNeutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea.Shared idiotopes among monoclonal antibodies specific for A/PR/8/34 (H1N1) and X-31(H3N2) influenza viruses.High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.Immunological principles and emerging strategies of vaccination for the elderly.Humoral immunity to HIV-1: neutralization and beyond.Pretreatment with lipoteichoic acid sensitizes target cells to antibody-dependent cellular cytotoxicity in the presence of anti-lipoteichoic acid antibodiesWhat Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.Evasion of influenza A viruses from innate and adaptive immune responses.Immunological assessment of influenza vaccines and immune correlates of protection.TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.
P2860
Q26783175-9DD5D86D-7AE1-4D16-86C8-AF17581E0300Q27024582-E090FD81-969B-487C-AA32-3D5606CDC20FQ28070255-518EBBDD-767B-4B94-9BAE-4374131ECDA9Q28242631-87F56893-F32D-48A9-8A46-A8645F3A2B95Q30333613-61700DE4-D547-4F7B-89F5-DF2E97892D84Q30354732-83AC7764-2386-4A34-B9EF-F8214535C906Q30363454-AFBC96E9-6BD4-49EA-B265-3240048F6808Q30366666-A03C8164-33C5-4C21-B795-C2D803B51C84Q30370445-206BCE41-B355-4C0D-83B9-BFB6EEE88DE2Q30377012-035CDB8D-B70E-4A62-BE7A-554DA0DA74C3Q30389916-5F9418B0-29EA-487E-90C6-2DE3F6B5496CQ30390233-C6490634-8B15-4F09-B722-A3B6CB6A00F9Q30400230-157654B0-8A8E-4ACA-809E-319C6DFBDCD4Q30407657-9C964309-6179-4C21-A901-9F97A9E355BDQ30425439-CF45778C-D9A6-4F82-94B6-958B5EF2BFAAQ30427950-9C80ABDF-7FAA-4715-AF61-0206CF596C26Q30428189-1952566F-4364-49B1-86E2-0F6B53ADB261Q30432591-CE1D0F48-C7B8-42D2-A2DC-5B39F4ACC71AQ33747251-9E00BAA5-3AB7-433C-BB04-594E3C447EC5Q33877811-4663E7DC-9FB6-4E5D-BB56-C8D63D9BBB86Q34283944-C311D0FB-6163-474B-A299-C46E1F22B1CEQ34354440-AA99DD1C-9024-4004-8848-263B145AD936Q34384402-34D51144-7EA6-4C7C-B0D4-26E77450897CQ34398563-899E3D5A-7008-4057-AF22-5790290EA051Q34990389-33E694A0-1D0E-4F14-9AA2-0E62A9CADA0DQ35000547-1725215E-A009-43D8-A034-78AC935A63B5Q35000739-CA0E6638-07A0-45D5-9403-FF02C6A1234AQ35167400-91802F5B-67E2-450F-9D80-50FFF678F31DQ35854491-007FDD0E-9051-45E9-B599-7D56420F3CF9Q36255877-7D3238C5-FA68-405E-9029-20A69E4007EEQ36344790-91B938AC-4479-4D13-9279-0C425D595108Q36728309-482843D0-CE7A-4539-8265-F3E7815B36C4Q36863847-4D8F4012-4326-48AB-81CB-2C0FBB6A5234Q37032812-9DA08080-92E2-41DD-A516-D9B29CCF12ADQ37034475-D44DC9F3-D93C-4B7B-85AF-202A44AB0EAAQ37336804-5A9F9053-DA6A-4D57-AA8F-ADC68F391315Q37418123-350DD506-D2D8-4456-B97A-BF622D58C611Q38061423-193361F0-6FB1-4357-8D0A-553DF2CFCBCAQ38105339-181D8610-462A-4368-A208-40B11B66C254Q38195597-A361B107-909F-41B3-B597-DAEBD6E773D6
P2860
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
description
1983 nî lūn-bûn
@nan
1983 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@ast
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@en
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@nl
type
label
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@ast
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@en
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@nl
prefLabel
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@ast
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@en
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@nl
P2093
P3181
P356
P1476
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells
@en
P2093
D T Karzon
G Hashimoto
P F Wright
P304
P3181
P356
10.1093/INFDIS/148.5.785
P407
P577
1983-11-01T00:00:00Z